Caffeine, an unspecific A2AR antagonist, was neuroprotective, as it lowered intraocular pressure and reduced the activation of microglia and the inflammatory cytokines IL-1β and TNF-α in a mouse glaucoma model (Madeira et al., 2016b). The gene discussed is ADORA2A; the disease is glaucoma.